This Article  • References  • Full text PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Farouk Karoum, PhD; Craig N. Karson, MD; Llewellyn B. Bigelow, MD; William B. Lawson, MD; Richard Jed Wyatt, MD

Arch Gen Psychiatry. 1987;44(7):604-607.

Abstract
• The mean combined total body excretion of dopamine (DA) and its metabolites, measured by summing the molar excretion of DA and its metabolites in 24-hour urine samples (Sum DA), was reduced in 20 patients with schizophrenia who had not been receiving medication for at least two weeks. These patients were relatively resistant to treatment, as they were unable to live independently outside institutional settings despite conventional neuroleptic therapy. In contrast, sum norepinephrine (Sum NE), measured by summing the molar excretion of NE and its metabolites, was not reduced. These results are highlighted by expressing the data in terms of the ratio of Sum DA/Sum NE. Patients with schizophrenia had a significantly lower ratio. Treatment with haloperidol normalized the low ratio. Urinary excretion of 5-hydroxyindoleacetic acid was normal in the schizophrenic patients. These results suggest that chronic schizophrenia is more likely to be associated with a low rather than a high state of DA activity.

Author Affiliations
From the Neuropsychiatry Branch, Intramural Research Program, National Institute of Mental Health, Saint Elizabeths Hospital, Washington, DC.

Footnotes
Accepted for publication March 10, 1987.

Reprint requests to Neuropsychiatry Branch, Intramural Research Program, National Institute of Mental Health, Saint Elizabeths Hospital, Washington, DC 20032 (Dr Karoum).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Plasma Homovanillic Acid Levels in First-Episode Schizophrenia: Psychopathology and Treatment Response
Koreen et al.
Arch Gen Psychiatry 1994;51:132-138.
ABSTRACT  

What Is Left of Attention in Schizophrenia?-Reply
POSNER
Arch Gen Psychiatry 1990;47:394-395.
ABSTRACT  

Biochemical Classifications of Diagnostic Subgroups and D-Type Scores
Potter and Linnoila
Arch Gen Psychiatry 1989;46:269-271.
ABSTRACT  

High Correlations of Norepinephrine, Dopamine, and Epinephrine and Their Major Metabolite Excretion Rates
Linnoila et al.
Arch Gen Psychiatry 1988;45:701-704.
ABSTRACT  

A Comparison of Plasma Homovanillic Acid Concentrations in Schizophrenic Patients and Normal Controls
Davidson and Davis
Arch Gen Psychiatry 1988;45:561-563.
ABSTRACT  

Plasma Monoamine Metabolites in Psychotic Disorders
Bowers
Arch Gen Psychiatry 1988;45:595-596.
ABSTRACT